1.
Clin Infect Dis
; 47(2): 222-4, 2008 Jul 15.
Artículo
en Inglés
| MEDLINE
| ID: mdl-18532890
RESUMEN
The treatment of fibrocavitatory pulmonary infection due to Mycobacterium avium complex and Mycobacterium malmoense poses a challenge. This study assessed microbial, inflammatory, radiographic, and clinical outcomes for a standardized 24-month triple-drug regime. Following treatment completion, all patients had fewer symptoms, experienced a reduction in systemic inflammation, and had negative sputum mycobacterial culture results.